IGC Pharma to Present Tau-PET Biomarker Research at 2026 Global Tau Conference
IGC Pharma will present a poster on Tau-PET biomarker research at the 2026 Global Tau Conference in Washington, D.C. The study analyzed 1,570 scans from 931 participants in the ADNI database, suggesting that focal tau spreading patterns correlate with worse cognitive outcomes in APOE4 carriers.
Key figures
- Study scans
- 1570
- Study participants
- 931
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.